Search Results - wenbin+tan

8 Results

Sort By:

Drug repurposing for treatment of congenital vascular malformations

Reference #: 1659 The University of South Carolina is offering licensing opportunities for Drug Repurposing for Treatment of Congenital Vascular Malformations. Background: Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation (CM), a.k.a.,...

Published: 7/1/2024 | Inventor(s): Wenbin Tan, Vi Nguyen, Chao Gao, Anil Jegga, Yunguan Wang, Sudhir Ghandikota, Marcelo Hochman

Keywords(s):

Category(s): Biomedical and Life Sciences, Health Sciences

Trigonelline mitigates cardiomyopathy caused by SARS-CoV-2 Spike protein under obesity

Reference #: 01642 The University of South Carolina is offering licensing opportunities for Trigonelline mitigates cardiomyopathy caused by SARS-CoV-2 spike protein under obesity. Background: Today, the spread of Coronavirus Disease 2019 (COVID-19) continues, and while millions of patients have recovered, a significant number experience prolonged...

Published: 5/17/2024 | Inventor(s): Wenbin Tan, Vi Nguyen, Taixing Cui

Keywords(s):

Category(s): Health Sciences, Biomedical and Life Sciences

Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation

Reference #: 01657 The University of South Carolina is offering licensing opportunities for Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation. Background: Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation...

Published: 4/25/2024 | Inventor(s): Wenbin Tan, Vi Nguyen, J. Stuart Nelson

Keywords(s):

Category(s): Biomedical and Life Sciences

SARS-COV-2 papain-like protease inhibitors as antivirals

Novel compounds and their use as an inhibitor for SARS-CoV-2. Invention Summary: Two oral SARS-CoV-2 antivirals are available, molnupiravir and Paxlovid. However, the limited efficacy, drug-drug interaction, and drug resistance are main challenges facing these two drugs. Additional oral antivirals with novel mechanisms of actions are clearly needed....

Published: 8/20/2024 | Inventor(s): Jun Wang, Edward Arnold, Francesc Ruiz Figueras, Prakash Jadhav, Bin Tan, Ahmadullah Ansari, Ashima Chopra

Keywords(s): Antiviral, Small molecules

Category(s): Technology Classifications > COVID-19, Technology Classifications > Infectious Disease, Technology Classifications > Therapeutics, Technology Classifications > Healthcare & Life Sciences

Tunable Degradation of Fibers

Executive Summary Degradation of polymeric materials is an important process in recycling, composting and rendering them innocuous to the environment. Controlling the rate by which the materials degrade remains challenging and impacted by the nature of the materials and their use in applications where combinations of materials exist to fulfil...

Published: 2/17/2023 | Inventor(s): John Dorgan, Bin Tan

Keywords(s):

Category(s): Advanced Materials, Environment, Packaging

Targeting Treatment For ADAM30 In Pathological Cells

Reference #: 01462 The University of South Carolina is offering licensing opportunities for Targeting treatment for ADAM30 in pathological cells Background: The treatment options for vascular malformations include conservative management, drug treatment, interventional radiology, laser therapy, excisional surgery and psychological treatment. However,...

Published: 9/3/2024 | Inventor(s): Wenbin Tan, Elaine Taine, Hui Wang, Vi Nguyen, Xialing Cao

Keywords(s): a disintegrin and metalloprotease (ADAM), antibody, biomarker, cancer, inhibitor, vascular malformation

Category(s): Health Sciences, Biomedical and Life Sciences

Exosome-Delivered Targeting Treatment for Blood Vessels

Reference #: 01455 The University of South Carolina is offering licensing opportunities for exosome-delivered targeting treatment for blood vessels Background: Vascular malformations cause a variety of severe symptoms, depending on body location and types of vasculatures involved, which makes clinical management very challenging. The treatment options...

Published: 9/4/2022 | Inventor(s): Wenbin Tan, Rong Yin, Li Meng

Keywords(s): congenital vascular anomalies, exosomes, laser, photodynamic therapy, targeting treatment

Category(s): Health Sciences, Biomedical and Life Sciences

Biomarkers for Congenital Vascular Malformations

Reference #: 01454 The University of South Carolina is offering licensing opportunities for Biomarkers for congenital vascular malformations Background: Vascular Malformations ae blemishes or masses on the body that may cause pain, swelling, or bleeding. VMs result from abnormal development in blood vessels, lymph vessels, or arteries, and are rare...

Published: 8/21/2024 | Inventor(s): Wenbin Tan, Elaine Taine

Keywords(s): biomarker, congenital vascular malformations, diagnosis

Category(s): Biomedical and Life Sciences, Health Sciences